[1]
A. Mendoza-Ticona, D. A. Moore, V. Alarcón, F. Samalvides, and C. Seas, “Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin”, Rev Peru Med Exp Salud Publica, vol. 30, no. 2, Feb. 2014, doi: 10.17843/rpmesp.2013.302.191.